Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
Can cryoglobulins be present in the setting of severe acrocyanosis without evidence of active cryoglobulinemic vasculitis?
Related Questions
How do you decide when to discontinue immunotherapy for primary angiitis of the central nervous system (PACNS)?
Have you seen microscopic polyangiitis associated with temporal artery involvement?
How do you treat IgA vasculitis with gastrointestinal involvement?
How would you approach management of a young woman referred for isolated active anterior scleritis with a history of resolved right eye iritis, in the absence of systemic manifestations or end-organ involvement, but with serologies notable for strongly positive MPO and p-ANCA antibodies?
Would you consider switching to benralizumab for patients with EGPA experiencing severe pulmonary symptoms despite being on mepolizumab?
What biologic or conventional/synthetic DMARD would you use as a steroid sparing agent in a patient with GCA and a history of diverticulitis?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
Would you consider re-dosing rituximab in a patient with ANCA vasculitis (early glomerulonephritis, pulmonary nodules, sinus symptoms) who experiences a flare of the disease and return of CD19 cells 3 months after initial rituximab administration?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
Do you always pursue biopsy confirmation before diagnosing IgA vasculitis?
